arrow
C

Chris Ka Pun Mok

HKU-Pasteur Research Pole
H指数:38
被引数:8,635

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical severity and co-infection of respiratory pathogens among children and adolescents with Mycoplasma pneumoniae infection in Guangzhou, China: a single-center retrospective cohort study

广州地区儿童和青少年支原体肺炎感染的临床严重程度及呼吸道病原体共感染情况:一项单中心回顾性队列研究

2026-09-050
OA
Structural basis for distinct protective mechanisms of IGHV3-23 antibodies targeting influenza hemagglutinin stem

靶向流感血凝素茎部的IGHV3-23抗体的不同保护机制的结构基础

2026-06-220
OAAI
Association between early SARS-CoV-2 viral rebound and post-COVID conditions among immunocompromised patients: cohort study

免疫抑制患者中早期SARS-CoV-2病毒反弹与长COVID状况的关联:队列研究

2026-04-070
PRE
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study

尼马曲韦/利托那韦和莫那比拉韦在降低新型冠状病毒肺炎短期和长期心血管并发症风险方面的有效性: 一项目标试验仿真研究

2025-12-210
OAAI
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study

Nirmatrelvir-ritonavir立即开始治疗对COVID后结果的更大益处: 一项基于人群的回顾性队列研究

2025-11-100
OAAI
Evolution of antibody cross-reactivity to influenza H5N1 neuraminidase from an N2-specific germline

来自N2特异性前体细胞的抗体交叉反应性对流感H5N1神经氨酸酶的演化

2025-10-170
PRE
The resident gut microbiome modulates the effect of synbiotics on the immunogenicity after SARS-COV-2 vaccination in elderly and diabetes patients

常住肠道微生物组调节合生元对老年和糖尿病患者SARS-COV-2疫苗接种后免疫原性的影响

2025-08-250
OAAI
SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study

新型冠状病毒肺炎患者的SARS-CoV-2反弹和急性后死亡率和住院: 队列研究

2025-07-280
OAAI
Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study

哮喘患者中尼玛特雷韦/利托那韦与莫诺拉韦的短期和长期比较疗效:一项队列研究

2025-02-280
OA
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation

nirmatrelvir/ritonavir和molnupiravir对门诊患者的post-COVID-19结果的有效性: 目标试验仿真研究

2025-02-180
OAAI
COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study

新型冠状病毒肺炎疫苗接种改善尼马瑞韦-利托那韦对急性后死亡率和再住院的影响: 一项回顾性队列研究

2024-11-040
OAAI
Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study

尼马曲韦-利托那韦与新型冠状病毒肺炎住院患者急性后遗症和死亡率的关系: 一项回顾性队列研究

2024-10-014
OAAI